Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KIR2DL3 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | CGGBP1 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
mRNA | MTMR7 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | IL1R2 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | ABCA13 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
mRNA | RYR2 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
mRNA | AMER2 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
mRNA | CROCC2 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-06 |
mRNA | MLXIPL | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
mRNA | INTS10 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |